DrugPatentWatch Database Preview
Helsinn Company Profile
What is the competitive landscape for HELSINN, and when can generic versions of HELSINN drugs launch?
HELSINN has five approved drugs.
There are thirty-two US patents protecting HELSINN drugs.
There are two hundred and sixty-nine patent family members on HELSINN drugs in sixty-seven countries and twenty-four supplementary protection certificates in fourteen countries.
Summary for Helsinn
| International Patents: | 269 |
| US Patents: | 32 |
| Tradenames: | 3 |
| Ingredients: | 4 |
| NDAs: | 5 |
| Patent Litigation for Helsinn: | See patent lawsuits for Helsinn |
| PTAB Cases with Helsinn as patent owner: | See PTAB cases with Helsinn as patent owner |
Drugs and US Patents for Helsinn
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-002 | Feb 29, 2008 | AP | RX | Yes | Yes | 9,173,942*PED | Start Trial | Y | Start Trial | ||
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-002 | Feb 29, 2008 | AP | RX | Yes | Yes | 9,457,020*PED | Start Trial | Y | Start Trial | ||
| Helsinn | VALCHLOR | mechlorethamine hydrochloride | GEL;TOPICAL | 202317-001 | Aug 23, 2013 | RX | Yes | Yes | 8,501,819 | Start Trial | Start Trial | ||||
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-002 | Feb 29, 2008 | AP | RX | Yes | Yes | 8,598,218*PED | Start Trial | Y | Start Trial | ||
| Helsinn Hlthcare | AKYNZEO | netupitant; palonosetron hydrochloride | CAPSULE;ORAL | 205718-001 | Oct 10, 2014 | RX | Yes | Yes | 9,186,357 | Start Trial | Start Trial | ||||
| Helsinn | VALCHLOR | mechlorethamine hydrochloride | GEL;TOPICAL | 202317-001 | Aug 23, 2013 | RX | Yes | Yes | 8,450,375 | Start Trial | Y | Start Trial | |||
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-001 | Jul 25, 2003 | AP | RX | Yes | Yes | 9,125,905*PED | Start Trial | Y | Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Helsinn
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Helsinn Hlthcare | AKYNZEO | netupitant; palonosetron hydrochloride | CAPSULE;ORAL | 205718-001 | Oct 10, 2014 | 5,202,333 | Start Trial |
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-001 | Jul 25, 2003 | 5,202,333*PED | Start Trial |
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-002 | Feb 29, 2008 | 5,202,333*PED | Start Trial |
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | CAPSULE;ORAL | 022233-001 | Aug 22, 2008 | 5,202,333 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Helsinn Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Croatia | P20161708 | Start Trial |
| Denmark | 1858864 | Start Trial |
| Spain | 2623503 | Start Trial |
| Peru | 14672000 | Start Trial |
| Israel | 232859 | Start Trial |
| Italy | MI20000328 | Start Trial |
| China | 107001275 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Helsinn Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1858864 | 295 50013-2017 | Slovakia | Start Trial | PRODUCT NAME: CHLORMETIN; REGISTRATION NO/DATE: EU/1/16/1171/001 20170306 |
| 1035115 | C300758 | Netherlands | Start Trial | PRODUCT NAME: NETUPITANT, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH; REGISTRATION NO/DATE: EU/1/15/1001 20150527 |
| 1858864 | PA2017026,C1858864 | Lithuania | Start Trial | PRODUCT NAME: CHLORMETINAS; REGISTRATION NO/DATE: EU/1/16/1171 20170303 |
| 1858864 | PA2017026 | Lithuania | Start Trial | PRODUCT NAME: CHLORMETINAS; REGISTRATION NO/DATE: EU/1/16/1171 20170303 |
| 1035115 | CA 2015 00044 | Denmark | Start Trial | PRODUCT NAME: NETUPITANT; REG. NO/DATE: EU/1/15/1001 20150527 |
| 1858864 | LUC00033 | Luxembourg | Start Trial | PRODUCT NAME: CHLORMETHINE ET SES DERIVES PHARMACEUTIQUEMENT ACCEPTABLES (LEDAGA); AUTHORISATION NUMBER AND DATE: EU/1/1671171 20170307 |
| 1858864 | 300888 | Netherlands | Start Trial | DETAILS ASSIGNMENT: CHANGE OF OWNER(S), ASSIGNMENT |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
